Abstract
Chronic conditions are now the leading reason why people seek medical care.1 The syndrome of heart failure (HF) is the final pathway for myriad diseases that affect the heart, and is a salient example of the challenge posed by chronic disease. Although the understanding of chronic HF pathophysiology has changed and therapeutic paradigms have been revolutionized, 2 a considerable burden of disability and unrelieved symptoms remains in optimally treated patients, with corresponding low quality of life, and poor prognosis which is worse than for many forms of cancer.3 In addition, the existence of multiple medical co-morbid conditions, an aging population, potential interaction among multiple medications and psychological impact combine to aggravate the complexity of HF management. Thus, HF is a chronic, costly, and life-threatening disorder, and the need for adequate management strategies is clear.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anderson GF. Physician, public and policymaker perspective on chronic conditions. Arch Intern Med 2003;163:437–442.
Massie BM. 15 years of heart failure trials: what have we learned? Lancet 1998;352:si29–si33.
Stewart S, MacIntyre K, Hole DJ, Capewell S, et al. More “malignant” than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 2001;3:315–322.
Balady GJ, Ades PA, Comoss P, et al. AHA/AACVPR Scientific Statement. Core components of cardiac rehabilitation/secondary prevention programs. Circulation 2000;102:1069–1073.
Kimmelstiel C, Levine D, Perry K, et al. Randomized, controlled evaluation of short-and long-term benefits of heart failure disease management within diverse provider network. The SPAN-CHF. Circulation 2005;110:1450–1455.
Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2001;38:2101–2113.
Guidelines for the diagnosis and treatment of chronic heart failure. Task force of European Society of Cardiology. Eur Heart J 2001;22:1527–1560.
Nohria A, Lewis E, Stevenson LW. Medical management of advanced heart failure. JAMA 2002;287:628–640.
Sharpe N. Clinical trials and the real world: selection bias and generalisability of trials results. Cardiovasc Drugs Ther 2002;16:75–77.
O’Connor CM, Joynt KE. Depression: are we ignoring an important comorbidity in heart failure? J Am Coll Cardiol 2004;43:1550–1552.
Luskin F, Reitz M, Newell K, et al. A controlled pilot study of stress management training in elderly patients with congestive heart failure. Prev Cardiol 2002;5:168–172.
Almeida OP, Flicker L. The mind of a failing heart: a systematic review of the association between congestive heart failure and cognitive functioning. Intern Med J 2001;31:290–295.
Horwich TB, Fonarow GC, Hamilton MA, et al. Anemia is associated with worse symptoms, greater impairment in functional capacity and significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002;39:1780–1786.
Silverberg DS, Wexler D, Blum M, et al. The use of subcutaneous erythropoietin and intravenous iron for treatment of the anemia of severe, resistant congestive heart failure improve cardiac and renal function and functional class, and markedly reduce hospitalizations. J Am Coll Cardiol 2000;35:1737–1744.
Mahon NG, Blackstone EH, Francis GS, et al. The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure. J Am Coll Cardiol 2002;40:1106–1113.
McAlister FA, Ezekowitz JA, Tonelli M, et al. Renal insufficiency and heart failure.Prognostic and therapeutic implications from a prospective cohort study. Circulation 2004;109:1004–1009.
McCullough PA. Why is chronic kidney disease the “spoiler” for cardiovascular outcomes? J Am Coll Cardiol 2003;41:725–728.
Anker SD, Sharma R. The syndrome of cardiac cachexia. Int J Cardiol 2002;85:51–66.
Anker SD, Coats AJS. Cardiac cachexia. A syndrome with impaired survival and immune and neuroendocrine activation. Chest 1999;115:836–847.
Ehrlich JR, Nattel S, Hohnloser SH. Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important cardiac disease sets. J Cardiovasc Electrophysiol 2002;13:399–405.
Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure: a study of 390 patients. Circulation 1991;84:40–48.
Carson PE, Johnson GR, Dunkman WB, et al. The influence of atrial fibrillation on prognosis in mild or moderate heart failure: the V-He FT VA Cooperative Studies Group. Circulation 1993;87:VI 102–VI 110.
Takarada A, Kurogane H, Hayashi T, et al. Prognostic significance of atrial fibrillation in dilated cardiomyopathy. Jpn Heart J 1993;34:749–758.
Lanfranchi PA, Somers VK, Braghiroli A, et al. Central sleep apnea in left ventricular dysfunction. Prevalence and implications for arrhythmic risk. Circulation 2003;107:727–732.
Lanfranchi PA, Braghiroli A, Bosimini E, et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 1999;99:1435–1444.
Quan SF, Gersh BJ. Cardiovascular consequences of sleep-disordered breathing: past, present and future. Circulation 2004;109:951–957.
Sinha AM, Skobel EC, Breithardt OA, et al. Cardiac resynchronization therapy improves central sleep apnea and Cheyne-Stokes respiration in patients with chronic heart failure. J Am Coll Cardiol 2004;44:68–71.
Komajda M, Follath F, Swedberg K, et al. The Euro-Heart Failure Survey programme — a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 2003;24:464–474.
Krumholz HM, Baker DW, Ashton CM, et al. Evaluating quality of care for patients with heart failure. Circulation 2000;101:e122–e140.
Colonna P, Sorino M, D’Agostino C, et al. Nonpharmacological care of heart failure: counselling, dietary restriction, rehabilitation, treatment of sleep apnea, and ultrafiltration. Am J Cardiol 2003;91(suppl):41F–50F.
Alpert MA, Terry BE, Mulekar M, et al. Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure and effect of weight loss. Am J Cardiol 1997;80:736–740.
Horwich TB, Fonarow GC, Hamilton MA, et al. The relationship between obesity and mortality in patients with advanced heart failure. J Am Coll Cardiol 2001;38:789–795.
Giannuzzi P, Mezzani A, Saner H, et al. Physical activity for primary and secondary prevention. Position paper of the Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology. Eur J Cardiovasc Prev Rehabil 2003;10(5):319–327.
Pantilat SZ, Steimle AE. Palliative care for patients with hart failure. JAMA 2004;291:2476–2482.
Smart N, Marwick TH. Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity. Am J Med 2004;116:693–706.
Piepoli MF, Davos C, Francis DP, Coats AJ; ExTra-MATCH Collaborative. Exercise training metaanalysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ 2004;328(7433):189.
McAlister FA, Stewart S, Ferrua S, et al. Multidisciplinary strategies for the management of heart failure patients at high risk for admission.A recent systematic review of randomized trial. J Am Coll Cardiol 2004;44:810–819.
Cline CMJ, Israelsson BYA, Willenheimer RB, et al. Cost effective management programme for heart failure reduces hospitalization. Heart 1998;80:442–446.
Stewart S, Marley JE, Horowitz JD. Effects of a multidisciplinary home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: a randomized controlled study. Lancet 1999;354:1077–1083.
Weinberger M, Oddone EZ, Henderson WG for the Veterans Affairs Cooperative Study Group on Primary Care and Hospital Readmissions. Does increased access to primary care reduce hospital readmissions? N Engl Med J 1996;334:1441–1447.
Krumholz HM, Amatruda J, Smith GL, et al. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol 2002;39:83–89.
Phillips CO, Wright SM, Kern DE, et al. Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure. A meta-analysis. JAMA 2004;291:1358–1367.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag London Limited
About this chapter
Cite this chapter
Corrà, U. (2007). Cardiac Rehabilitation in Chronic Heart Failure. In: Perk, J., et al. Cardiovascular Prevention and Rehabilitation. Springer, London. https://doi.org/10.1007/978-1-84628-502-8_48
Download citation
DOI: https://doi.org/10.1007/978-1-84628-502-8_48
Publisher Name: Springer, London
Print ISBN: 978-1-84628-462-5
Online ISBN: 978-1-84628-502-8
eBook Packages: MedicineMedicine (R0)